Brief: Lisata Therapeutics Reports Third Quarter 2022 Financial Results And Provides Business Update
10/11/2022 22:03
Nov 10 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* LISATA THERAPEUTICS INC QTRLY LOSS PER SHARE $7.88
Source text for Eikon: ID:nGNX8HnM3V
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco